Cancer Genetics and Psychotherapy

The aim of this book is to provide the readers with the most comprehensive and latest accounts of research and development in this field by emphasizing on the manner of relation between doctors and cancer patients in direction of improving the patients' style of life. This book, partly, will deal with psychotherapy by considering cancer patients, benefits, hazards and also social impacts including life style. The social supports as the key and influential paradigms will be challenged as a comparative insight by considering the global unity in order to provide a reasonable model to improve the interaction between cancer and psychological nest.

In this book, the real stories of cancer patient will be also provided.

 

The initial insight of sections includes:

1)    Brief classifications and key points of clinical and histopatological aspects of each organ.

2)    Brief view of genetic alterations in each organ.

3)    Therapeutic aspects.

4)    Brief classifications and key points of Psychology in cancer.

5) The interactions of clinical aspects with psychological field.

Professor Parvin Mehdipour has mainly focused on Cancer Genetics by considering the multi-disciplinary manner in her academic and research life through 34 years in Tehran University of Medical Sciences. She was inspired by puzzling the road maps of Genetic and tumor biology to find the directions and cross roads in cancer and cross-talk between the cancer cells. She had scientific links with DKFZ, Institutes of Human Genetics and Institute of Medical Genetics in Erlangen-Nuerenberg, Bonn, Humboldt/berlin, Dresden- and Manchester- University. She has initiated a cancer project on leukemia at Department of Genetics, Royal Liverpool hospital, University of Liverpool as her PhD thesis. Since then she was exploring on solid tumors to prove the cancer evolution and hypotheses in different cancers including breast and brain tumors and also tracing cancer biomarkers. Her aims and focal interests during last 20 years included early detection through Circulating Tumor Cells (CTCs) in cancer journey and innovating modeling of the metastatic cancer. The final destination of her task is personalized cancer managements and drug innovation. Her interests include painting, writing and nutrigenomics.